GlassScriptPhysician profile
Savannah Tanner
NPI 1700291648
$1,912.25
in general payments reported to CMS, 2019-2025
14 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.21 · 2022: $472 · 2023: $589 · 2024: $338 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $655.83 | 2021-2025 | |
| Amgen INC. | $232.25 | 2021-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $231.68 | 2022-2025 | Wainua, Farxiga |
| Medtronic, INC. | $194.53 | 2022-2023 | Onyx Frontier |
| Actelion Pharmaceuticals US, INC. | $125.69 | 2024 | Uptravi, Opsumit |
| Janssen Scientific Affairs, LLC | $119.95 | 2022 | |
| Abiomed | $76.37 | 2025 | |
| Atricure, INC. | $57.44 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $54.35 | 2021-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $53.88 | 2022-2023 | Verquvo |
| Alnylam Pharmaceuticals INC. | $38.28 | 2022-2025 | Amvuttra |
| Baxter Healthcare | $33.65 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Chiesi USA, INC. | $20.00 | 2024 | Cleviprex, Kengreal |
| Scpharmaceuticals INC. | $18.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savannah Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.